Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
FDA clears 4D visualization platform | Tricuspid valve surgery outcomes | Real-world TAVR data vs. clinical trials
Thursday, April 17, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA clears catheter-based 4D visualization platform for complex heart procedures

The new technology from LUMA Vision allows operators to deliver 2D and 4D ultrasound images in real time. The advanced catheter was built with maneuverability and increased visibility in mind.

READ MORE >
Luma Vision Verafeye Visualization Platform. The Verafeye Visualization Platform allows operators to deliver 2D and 4D ultrasound images in real time. The catheter was built with maneuverability and increased visibility in mind; it can capture images of up to 120 mm from the tip and provide views of the patient’s anatomy from all angles.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears catheter-based 4D visualization platform for complex heart procedures

Share on Twitter Share on Facebook Share on Linkedin
Luma Vision Verafeye Visualization Platform. The Verafeye Visualization Platform allows operators to deliver 2D and 4D ultrasound images in real time. The catheter was built with maneuverability and increased visibility in mind; it can capture images of up to 120 mm from the tip and provide views of the patient’s anatomy from all angles.
The new technology from LUMA Vision allows operators to deliver 2D and 4D ultrasound images in real time. The advanced catheter was built with maneuverability and increased visibility in mind.
READ MORE >

No longer the ‘forgotten valve’: Tricuspid valve surgery outcomes keep improving

Patient outcomes after tricuspid valve replacement have improved significantly over the years, according to new data published in The Annals of Thoracic Surgery.

READ MORE >
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Share on Twitter Share on Facebook Share on Linkedin

No longer the ‘forgotten valve’: Tricuspid valve surgery outcomes keep improving

Share on Twitter Share on Facebook Share on Linkedin
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Patient outcomes after tricuspid valve replacement have improved significantly over the years, according to new data published in The Annals of Thoracic Surgery.
READ MORE >

Death after 1 year more common for real-world low-risk TAVR patients than those treated in clinical trials

Real-world patients were still associated with "excellent" outcomes, but it is important for cardiologists and patients alike to know as much as possible about the odds of survival following treatment. 

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

Death after 1 year more common for real-world low-risk TAVR patients than those treated in clinical trials

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
Real-world patients were still associated with "excellent" outcomes, but it is important for cardiologists and patients alike to know as much as possible about the odds of survival following treatment. 
READ MORE >

Featured Articles

Implantable IVC sensor shows early potential to guide heart failure management

The goal is to measure changes in a patient’s IVC area and collapsibility, which can help anticipate when heart failure events might occur. This first-in-human study included data from the first 50 patients to receive the device. 

READ MORE >
The FIRE1 Norm inferior vena cava (IVC) heart failure sensor. It is implant in the inferior vena cava (IVC) to track changes in intravascular fluid volume is both safe and feasible, according to new findings published in JACC: Heart Failure.
Share on Twitter Share on Facebook Share on Linkedin

Implantable IVC sensor shows early potential to guide heart failure management

Share on Twitter Share on Facebook Share on Linkedin
The FIRE1 Norm inferior vena cava (IVC) heart failure sensor. It is implant in the inferior vena cava (IVC) to track changes in intravascular fluid volume is both safe and feasible, according to new findings published in JACC: Heart Failure.
The goal is to measure changes in a patient’s IVC area and collapsibility, which can help anticipate when heart failure events might occur. This first-in-human study included data from the first 50 patients to receive the device. 
READ MORE >

Enabling X-ray-free ablation procedures in the EP lab

Sponsored by Johnson & Johnson MedTech

Exposure to scatter radiation and orthopedic issues related to years of wearing lead aprons during long EP procedures has led electrophysiologists to seek out new ways to reduce the need for angiographic X-ray.

READ MORE >
doctor examines patient data on their tablet
Share on Twitter Share on Facebook Share on Linkedin

Enabling X-ray-free ablation procedures in the EP lab

Sponsored by Johnson & Johnson MedTech

Share on Twitter Share on Facebook Share on Linkedin
doctor examines patient data on their tablet
Exposure to scatter radiation and orthopedic issues related to years of wearing lead aprons during long EP procedures has led electrophysiologists to seek out new ways to reduce the need for angiographic X-ray.
READ MORE >

FDA clears AI-powered echocardiography software

HeartFocus guides users through the entire process, making it so that even novices can deliver high-quality echocardiograms every time.

READ MORE >
HeartFocus DESKi
Share on Twitter Share on Facebook Share on Linkedin

FDA clears AI-powered echocardiography software

Share on Twitter Share on Facebook Share on Linkedin
HeartFocus DESKi
HeartFocus guides users through the entire process, making it so that even novices can deliver high-quality echocardiograms every time.
READ MORE >

New drug reverses antiplatelet effects of ticagrelor, helping surgeons avoid a 'bloody mess'

Deepak Bhatt, MD, believes bentracimab could be a game-changer if it gains approval. "I think it's the sort of drug that every emergency room and ICU would have to stock," he said. "A cardiac care unit would have to stock a couple of doses, as would every cath lab."

READ MORE >
Video of Deepak Bhatt explaining the benefits of bentracimab in the late-breaking Phase 3 REVERSE-IT trial.
Share on Twitter Share on Facebook Share on Linkedin

New drug reverses antiplatelet effects of ticagrelor, helping surgeons avoid a 'bloody mess'

Share on Twitter Share on Facebook Share on Linkedin
Video of Deepak Bhatt explaining the benefits of bentracimab in the late-breaking Phase 3 REVERSE-IT trial.
Deepak Bhatt, MD, believes bentracimab could be a game-changer if it gains approval. "I think it's the sort of drug that every emergency room and ICU would have to stock," he said. "A cardiac care unit would have to stock a couple of doses, as would every cath lab."
READ MORE >

FDA approves leadless CRT device for heart failure

The WiSE CRT system is approximately the size of a single cooked grain of rice. It works with a patient’s existing implant to provide biventricular pacing. 

READ MORE >
The tiny WiSE CRT system from EBR Systems enables leadless pacing. The WiSE CRT system is approximately the size of a single cooked grain of rice. It works with a patient’s existing implant to provide biventricular pacing.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves leadless CRT device for heart failure

Share on Twitter Share on Facebook Share on Linkedin
The tiny WiSE CRT system from EBR Systems enables leadless pacing. The WiSE CRT system is approximately the size of a single cooked grain of rice. It works with a patient’s existing implant to provide biventricular pacing.
The WiSE CRT system is approximately the size of a single cooked grain of rice. It works with a patient’s existing implant to provide biventricular pacing. 
READ MORE >

In Case You Missed It

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS

Two separate studies at ACC.25 explored data from the EARLY TAVR trial. One analysis included stroke findings that surprised researchers.

READ MORE >
Philippe Généreux, MD, presenting late-breaking clinical research on TAVR at ACC.25
Share on Twitter Share on Facebook Share on Linkedin

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS

Share on Twitter Share on Facebook Share on Linkedin
Philippe Généreux, MD, presenting late-breaking clinical research on TAVR at ACC.25
Two separate studies at ACC.25 explored data from the EARLY TAVR trial. One analysis included stroke findings that surprised researchers.
READ MORE >

Dapagliflozin improves outcomes for elderly TAVR patients with heart failure

The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.

READ MORE >
Sergio Raposeiras-Roubin, MD, presenting new data on TAVR and dapagliflozin at ACC.25 in Chicago
Share on Twitter Share on Facebook Share on Linkedin

Dapagliflozin improves outcomes for elderly TAVR patients with heart failure

Share on Twitter Share on Facebook Share on Linkedin
Sergio Raposeiras-Roubin, MD, presenting new data on TAVR and dapagliflozin at ACC.25 in Chicago
The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.
READ MORE >

Bringing state-of-the-art healthcare to Florida heart patients

Naples Comprehensive Health is building up what it hopes will be a nationally recognized cardiology program. Robert Cubeddu, MD, and Dee Dee Wang, MD, spoke with Cardiovascular Business about the journey so far. 

READ MORE >
NCH Rooney Heart Center is building a comprehensive program in Florida.
Share on Twitter Share on Facebook Share on Linkedin

Bringing state-of-the-art healthcare to Florida heart patients

Share on Twitter Share on Facebook Share on Linkedin
NCH Rooney Heart Center is building a comprehensive program in Florida.
Naples Comprehensive Health is building up what it hopes will be a nationally recognized cardiology program. Robert Cubeddu, MD, and Dee Dee Wang, MD, spoke with Cardiovascular Business about the journey so far. 
READ MORE >

In Other News

RadNet to acquire breast imaging AI vendor iCAD for $103M

The acquisition will give Los Angeles-based RadNet an installed base of more than 1,500 healthcare provider locations, facilitating 8 million mammograms across 50 countries. 

READ MORE >
Artificial intelligence can help make breast cancer screening mammography more accurate.
Share on Twitter Share on Facebook Share on Linkedin

RadNet to acquire breast imaging AI vendor iCAD for $103M

Share on Twitter Share on Facebook Share on Linkedin
Artificial intelligence can help make breast cancer screening mammography more accurate.
The acquisition will give Los Angeles-based RadNet an installed base of more than 1,500 healthcare provider locations, facilitating 8 million mammograms across 50 countries. 
READ MORE >

Newswatch: AI researchers weigh in, AI humanizes healthcare, ‘the worst AI will ever be,’ more

Contrary to popular misgivings, AI may be improving the human touch in healthcare. 

READ MORE >
doctor patient human touch
Share on Twitter Share on Facebook Share on Linkedin

Newswatch: AI researchers weigh in, AI humanizes healthcare, ‘the worst AI will ever be,’ more

Share on Twitter Share on Facebook Share on Linkedin
doctor patient human touch
Contrary to popular misgivings, AI may be improving the human touch in healthcare. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup